"pfizer-biontech-covid-19-vaccine"

Washington: A US Centers for Disease Control and Prevention (CDC) advisory panel has endorsed booster shots of the Pfizer-BioNTech Covid-19 vaccine for Americans aged 65 and older, as well as for people with certain high risk conditions. The panel on Thursday voted 15-0 to recommend the booster dose for Americans age 65 and older and […]

Even a single dose of the mRNA vaccines can reduce the risk of infection by 81 per cent. These estimates included symptomatic and asymptomatic infections.

The Pfizer/BioNTech COVID-19 vaccine is already approved for use in adults and adolescents aged 16 years and above.

Nearly 51 per cent of Moderna recipients had full-body symptoms, compared with 48 per cent of people who got the Pfizer/BioNTech shot.

BioNTech and Fosun Pharma have not found any reason to believe the product is unsafe, according to a statement by the Hong Kong government.

Trudeau has previously said the country will receive 249,000 initial doses of the vaccine this month, the first 30,000 doses of which are expected to have arrived by Monday.

"I am authorizing the emergency use of Pfizer-BioNTech COVID?19 Vaccine for the prevention of COVID-19," Denise Hinton, the Food and Drug Administration's chief scientist wrote in a letter to a Pfizer executive.

The Canadian government has said its target is to vaccinate majority of the citizens by September 2021.

The UK will be the first country in the world to start using the Pfizer vaccine after regulators approved its use last week.

Latest figures on Tuesday showed that the country had recorded a total of 259,600 Covid deaths and 12.5 million cases -- with over 2,000 deaths and 167,000 new cases in just the last 24 hours.